Mendus AB (publ) (STO:IMMU)
7.35
+0.21 (2.94%)
Sep 2, 2026, 5:29 PM CET
Mendus AB Revenue
Mendus AB had revenue of 3.89M SEK in the quarter ending June 30, 2026, with 213.37% growth. This brings the company's revenue in the last twelve months to 15.82M, up 274.86% year-over-year. In the year 2025, Mendus AB had annual revenue of 7.90M.
Revenue (ttm)
15.82M
Revenue Growth
+274.86%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
19
Market Cap
487.41M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.90M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 29.61M | 26.24M | 777.42% |
| Dec 31, 2022 | 3.38M | 3.34M | 10,787.10% |
| Dec 31, 2021 | 31.00K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | 33.38M | 33.01M | 8,970.65% |
| Dec 31, 2018 | 368.00K | 150.00K | 68.81% |
| Dec 31, 2017 | 218.00K | - | - |
| Dec 31, 2016 | 0 | - | - |
| Jun 30, 2016 | - | - | - |
| Jun 30, 2015 | 160.00K | -400.00K | -71.43% |
| Jun 30, 2014 | 560.00K | 558.53K | 37,917.65% |
| Jun 30, 2013 | 1.47K | -137.53K | -98.94% |
| Jun 30, 2012 | 139.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cantargia AB | 317.31M |
| Sprint Bioscience AB | 138.95M |
| AlzeCure Pharma AB | 97.33M |
| Oncopeptides AB | 95.15M |
| IRLAB Therapeutics AB | 79.33M |
| Intervacc AB | 18.11M |
| Corline Biomedical AB | 11.85M |
| Xspray Pharma AB | 2.47M |
Mendus AB News
- 13 days ago - Mendus AB Earnings Call Transcript: Q2 2026 - Transcripts
- 13 days ago - Mendus AB Quarterly report: Q2 2026 - Filings
- 13 days ago - Mendus AB Slides: Corporate presentation - Filings
- 3 months ago - Mendus AB Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - Mendus AB Quarterly report: Q1 2026 - Filings
- 3 months ago - Mendus AB Slides: Q1 2026 - Filings
- 4 months ago - Mendus AB Slides: Corporate presentation - Filings
- 6 months ago - Mendus AB Earnings Call Transcript: Q4 2025 - Transcripts